
Global Polio Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Description
Global Polio Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Polio Vaccine segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Polio Vaccine segment by Application
Public
Private
Polio Vaccine segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Polio Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Polio Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Polio Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Polio Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polio Vaccine industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Polio Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Table of Contents
192 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Polio Vaccine Sales Value (2019-2030)
- 1.2.2 Global Polio Vaccine Sales Volume (2019-2030)
- 1.2.3 Global Polio Vaccine Sales Average Price (2019-2030)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Polio Vaccine Market Dynamics
- 2.1 Polio Vaccine Industry Trends
- 2.2 Polio Vaccine Industry Drivers
- 2.3 Polio Vaccine Industry Opportunities and Challenges
- 2.4 Polio Vaccine Industry Restraints
- 3 Polio Vaccine Market by Company
- 3.1 Global Polio Vaccine Company Revenue Ranking in 2023
- 3.2 Global Polio Vaccine Revenue by Company (2019-2024)
- 3.3 Global Polio Vaccine Sales Volume by Company (2019-2024)
- 3.4 Global Polio Vaccine Average Price by Company (2019-2024)
- 3.5 Global Polio Vaccine Company Ranking, 2022 VS 2023 VS 2024
- 3.6 Global Polio Vaccine Company Manufacturing Base & Headquarters
- 3.7 Global Polio Vaccine Company, Product Type & Application
- 3.8 Global Polio Vaccine Company Commercialization Time
- 3.9 Market Competitive Analysis
- 3.9.1 Global Polio Vaccine Market CR5 and HHI
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
- 3.9.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
- 3.10 Mergers & Acquisitions, Expansion
- 4 Polio Vaccine Market by Type
- 4.1 Polio Vaccine Type Introduction
- 4.1.1 Inactivated Polio Vaccine (IPV)
- 4.1.2 Oral Polio Vaccine (OPV)
- 4.2 Global Polio Vaccine Sales Volume by Type
- 4.2.1 Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
- 4.2.2 Global Polio Vaccine Sales Volume by Type (2019-2030)
- 4.2.3 Global Polio Vaccine Sales Volume Share by Type (2019-2030)
- 4.3 Global Polio Vaccine Sales Value by Type
- 4.3.1 Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
- 4.3.2 Global Polio Vaccine Sales Value by Type (2019-2030)
- 4.3.3 Global Polio Vaccine Sales Value Share by Type (2019-2030)
- 5 Polio Vaccine Market by Application
- 5.1 Polio Vaccine Application Introduction
- 5.1.1 Public
- 5.1.2 Private
- 5.2 Global Polio Vaccine Sales Volume by Application
- 5.2.1 Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
- 5.2.2 Global Polio Vaccine Sales Volume by Application (2019-2030)
- 5.2.3 Global Polio Vaccine Sales Volume Share by Application (2019-2030)
- 5.3 Global Polio Vaccine Sales Value by Application
- 5.3.1 Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
- 5.3.2 Global Polio Vaccine Sales Value by Application (2019-2030)
- 5.3.3 Global Polio Vaccine Sales Value Share by Application (2019-2030)
- 6 Polio Vaccine Market by Region
- 6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
- 6.2 Global Polio Vaccine Sales by Region (2019-2030)
- 6.2.1 Global Polio Vaccine Sales by Region: 2019-2024
- 6.2.2 Global Polio Vaccine Sales by Region (2025-2030)
- 6.3 Global Polio Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
- 6.4 Global Polio Vaccine Sales Value by Region (2019-2030)
- 6.4.1 Global Polio Vaccine Sales Value by Region: 2019-2024
- 6.4.2 Global Polio Vaccine Sales Value by Region (2025-2030)
- 6.5 Global Polio Vaccine Market Price Analysis by Region (2019-2024)
- 6.6 North America
- 6.6.1 North America Polio Vaccine Sales Value (2019-2030)
- 6.6.2 North America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
- 6.7 Europe
- 6.7.1 Europe Polio Vaccine Sales Value (2019-2030)
- 6.7.2 Europe Polio Vaccine Sales Value Share by Country, 2023 VS 2030
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Polio Vaccine Sales Value (2019-2030)
- 6.8.2 Asia-Pacific Polio Vaccine Sales Value Share by Country, 2023 VS 2030
- 6.9 Latin America
- 6.9.1 Latin America Polio Vaccine Sales Value (2019-2030)
- 6.9.2 Latin America Polio Vaccine Sales Value Share by Country, 2023 VS 2030
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Polio Vaccine Sales Value (2019-2030)
- 6.10.2 Middle East & Africa Polio Vaccine Sales Value Share by Country, 2023 VS 2030
- 7 Polio Vaccine Market by Country
- 7.1 Global Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030
- 7.2 Global Polio Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
- 7.3 Global Polio Vaccine Sales by Country (2019-2030)
- 7.3.1 Global Polio Vaccine Sales by Country (2019-2024)
- 7.3.2 Global Polio Vaccine Sales by Country (2025-2030)
- 7.4 Global Polio Vaccine Sales Value by Country (2019-2030)
- 7.4.1 Global Polio Vaccine Sales Value by Country (2019-2024)
- 7.4.2 Global Polio Vaccine Sales Value by Country (2025-2030)
- 7.5 USA
- 7.5.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.5.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.5.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.6 Canada
- 7.6.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.6.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.6.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.7 Germany
- 7.7.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.7.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.7.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.8 France
- 7.8.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.8.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.8.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.9 U.K.
- 7.9.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.9.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.9.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.10 Italy
- 7.10.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.10.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.10.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.11 Netherlands
- 7.11.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.11.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.11.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.12 Nordic Countries
- 7.12.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.12.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.12.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.13 China
- 7.13.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.13.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.13.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.14 Japan
- 7.14.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.14.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.14.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.15 South Korea
- 7.15.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.15.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.15.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.16 Southeast Asia
- 7.16.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.16.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.16.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.17 India
- 7.17.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.17.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.17.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.18 Australia
- 7.18.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.18.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.18.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.19 Mexico
- 7.19.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.19.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.19.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.20 Brazil
- 7.20.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.20.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.20.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.21 Turkey
- 7.21.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.21.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.21.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.22 Saudi Arabia
- 7.22.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.22.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.22.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 7.23 UAE
- 7.23.1 Global Polio Vaccine Sales Value Growth Rate (2019-2030)
- 7.23.2 Global Polio Vaccine Sales Value Share by Type, 2023 VS 2030
- 7.23.3 Global Polio Vaccine Sales Value Share by Application, 2023 VS 2030
- 8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Comapny Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.1.4 Sanofi Polio Vaccine Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 GSK
- 8.2.1 GSK Comapny Information
- 8.2.2 GSK Business Overview
- 8.2.3 GSK Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.2.4 GSK Polio Vaccine Product Portfolio
- 8.2.5 GSK Recent Developments
- 8.3 Bibcol
- 8.3.1 Bibcol Comapny Information
- 8.3.2 Bibcol Business Overview
- 8.3.3 Bibcol Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.3.4 Bibcol Polio Vaccine Product Portfolio
- 8.3.5 Bibcol Recent Developments
- 8.4 Serum Institute
- 8.4.1 Serum Institute Comapny Information
- 8.4.2 Serum Institute Business Overview
- 8.4.3 Serum Institute Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.4.4 Serum Institute Polio Vaccine Product Portfolio
- 8.4.5 Serum Institute Recent Developments
- 8.5 Tiantan Biological
- 8.5.1 Tiantan Biological Comapny Information
- 8.5.2 Tiantan Biological Business Overview
- 8.5.3 Tiantan Biological Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
- 8.5.5 Tiantan Biological Recent Developments
- 8.6 IMBCA
- 8.6.1 IMBCA Comapny Information
- 8.6.2 IMBCA Business Overview
- 8.6.3 IMBCA Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.6.4 IMBCA Polio Vaccine Product Portfolio
- 8.6.5 IMBCA Recent Developments
- 8.7 Panacea Biotec Ltd
- 8.7.1 Panacea Biotec Ltd Comapny Information
- 8.7.2 Panacea Biotec Ltd Business Overview
- 8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
- 8.7.5 Panacea Biotec Ltd Recent Developments
- 8.8 Bio-Med
- 8.8.1 Bio-Med Comapny Information
- 8.8.2 Bio-Med Business Overview
- 8.8.3 Bio-Med Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.8.4 Bio-Med Polio Vaccine Product Portfolio
- 8.8.5 Bio-Med Recent Developments
- 8.9 Halfkin Bio-Pharmaceuticals
- 8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
- 8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
- 8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Value and Gross Margin (2019-2024)
- 8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
- 8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Polio Vaccine Value Chain Analysis
- 9.1.1 Polio Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Polio Vaccine Sales Mode & Process
- 9.2 Polio Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Polio Vaccine Distributors
- 9.2.3 Polio Vaccine Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.